Oncolytics Biotech® Inc. , a leading clinical-stage company specializing in immunotherapy for oncology, today announced that Germany's medical regulatory body, the Paul-Ehrlich-Institute (PEI), has ...
ExtremeTech on MSN43m
Stanford Medicine's AI Model Accurately Predicts Cancer Prognoses, Treatment EfficacyThe model is the first of its kind to use multiple types of imaging and language-based data to assess a cancer patient's ...
Cancer is a disease of the genome, according to Dr. Elli Papaemmanuil, computational oncologist at MSK. By looking at the ...
A significant 81% of executives and 96% of their teams are already leveraging AI to a moderate or significant degree, with ...
Hosted on MSN6h
From cancer to diabetic retinopathy, how AIIMS is betting big on AI to aid in diagnosticsArogya Aarohan app & other AI-driven tools are being tested for early detection of diseases as part of Rs 300-cr initiative ...
Artificial intelligence (AI)-supported double-reading mammography is associated with a higher breast cancer detection ...
Companies from Johnson & Johnson to Eli Lilly, Amazon and Nvidia are announcing health-related deals at the JPMorgan Health ...
Welcome to the Novartis presentation at the 43rd JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan. It's my great pleasure to introduce Vas Narasimhan, the CEO ...
A RECENT observational study has shown that AI can significantly enhance breast cancer detection rates in mammography ...
Karen Huntsman said she would do anything to spread the message that early cancer detection saves lives — and that includes personally riding on ...
The manuscript topics to cover are but are not limited to: -Real-world evidence on managing treatment-resistant breast cancer. -Translational research linking laboratory findings to clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback